KURA logo

Kura Oncology (KURA) Shareholders Equity

KURA Annual Shareholders Equity

$397.27 M
-$23.00 M-5.47%

31 December 2023

KURA Shareholders Equity Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

KURA Quarterly Shareholders Equity

$423.77 M
-$42.30 M-9.08%

30 September 2024

KURA Quarterly Shareholders Equity Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

KURA Shareholders Equity Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-5.5%+6.7%
3 y3 years-35.0%+6.7%
5 y5 years+146.8%+6.7%

KURA Shareholders Equity High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-21.6%at low-16.4%+7.2%
5 y5-year-35.0%+81.6%-30.6%+108.5%
alltimeall time-35.0%>+9999.0%-30.6%+1021.6%

Kura Oncology Shareholders Equity History

DateAnnualQuarterly
Sept 2024
-
$423.77 M(-9.1%)
June 2024
-
$466.07 M(-7.7%)
Mar 2024
-
$505.08 M(+27.1%)
Dec 2023
$397.27 M(-5.5%)
$397.27 M(-7.6%)
Sept 2023
-
$429.94 M(-6.5%)
June 2023
-
$459.68 M(+16.3%)
Mar 2023
-
$395.18 M(-6.0%)
Dec 2022
$420.28 M(-17.0%)
$420.28 M(+0.2%)
Sept 2022
-
$419.62 M(-6.6%)
June 2022
-
$449.49 M(-5.6%)
Mar 2022
-
$476.25 M(-6.0%)
Dec 2021
$506.61 M(-17.1%)
$506.61 M(-5.1%)
Sept 2021
-
$533.76 M(-4.4%)
June 2021
-
$558.55 M(-4.7%)
Mar 2021
-
$585.99 M(-4.1%)
Dec 2020
$610.90 M(+179.2%)
$610.90 M(+99.3%)
Sept 2020
-
$306.50 M(-4.9%)
June 2020
-
$322.37 M(+58.6%)
Mar 2020
-
$203.20 M(-7.1%)
DateAnnualQuarterly
Dec 2019
$218.78 M(+35.9%)
$218.78 M(-6.3%)
Sept 2019
-
$233.58 M(-5.3%)
June 2019
-
$246.58 M(+64.9%)
Mar 2019
-
$149.56 M(-7.1%)
Dec 2018
$160.99 M(+101.6%)
$160.99 M(-7.8%)
Sept 2018
-
$174.61 M(+55.3%)
June 2018
-
$112.40 M(-9.9%)
Mar 2018
-
$124.80 M(+56.3%)
Dec 2017
$79.86 M(+40.4%)
$79.86 M(-10.5%)
Sept 2017
-
$89.20 M(+104.4%)
June 2017
-
$43.64 M(-13.1%)
Mar 2017
-
$50.24 M(-11.7%)
Dec 2016
$56.88 M(-30.7%)
$56.88 M(-10.7%)
Sept 2016
-
$63.67 M(-9.1%)
June 2016
-
$70.04 M(-7.9%)
Mar 2016
-
$76.07 M(-7.4%)
Dec 2015
$82.10 M(-2491.6%)
$82.10 M(+117.3%)
Sept 2015
-
$37.78 M
Dec 2014
-$3.43 M
-

FAQ

  • What is Kura Oncology annual stockholders equity?
  • What is the all time high annual shareholders equity for Kura Oncology?
  • What is Kura Oncology annual shareholders equity year-on-year change?
  • What is Kura Oncology quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for Kura Oncology?
  • What is Kura Oncology quarterly shareholders equity year-on-year change?

What is Kura Oncology annual stockholders equity?

The current annual shareholders equity of KURA is $397.27 M

What is the all time high annual shareholders equity for Kura Oncology?

Kura Oncology all-time high annual stockholders equity is $610.90 M

What is Kura Oncology annual shareholders equity year-on-year change?

Over the past year, KURA annual stockholders equity has changed by -$23.00 M (-5.47%)

What is Kura Oncology quarterly stockholders equity?

The current quarterly shareholders equity of KURA is $423.77 M

What is the all time high quarterly shareholders equity for Kura Oncology?

Kura Oncology all-time high quarterly stockholders equity is $610.90 M

What is Kura Oncology quarterly shareholders equity year-on-year change?

Over the past year, KURA quarterly stockholders equity has changed by +$26.50 M (+6.67%)